H3N2 M2SR Influenza Vaccine - FluGenAlternative Names: H3N2 M2SR Monovalent Influenza Vaccine; H3N2 viral vaccine - FluGen
Latest Information Update: 26 Jul 2016
At a glance
- Originator FluGen
- Class Influenza A vaccines; Vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Influenza A virus H3N2 subtype
Most Recent Events
- 29 Jun 2016 Phase-I clinical trials in Influenza-A virus H3N2 subtype (Prevention) in USA (Intranasal) (NCT02822105)